Status:
RECRUITING
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Lead Sponsor:
Baskent University
Collaborating Sponsors:
Hacettepe University
Conditions:
Chemotherapy-induced Nausea and Vomiting
Pediatric Cancer
Eligibility:
All Genders
7-18 years
Phase:
NA
Brief Summary
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either gui...
Detailed Description
Despite significant advances in anti-emetic treatment, chemotherapy induced nausea and vomiting (CINV) is considered a major side-effect that significantly reduces the quality of life of children diag...
Eligibility Criteria
Inclusion
- 7 to 18 years old,
- who will receive intravenous chemotherapy,
- no cognitive or neurological disease that would prevent communication,
- receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification,
- no verbal, visual and auditory communication disabilities (ability to speak Turkish, no mental deficiency),
- children whose parents and themselves volunteered to participate in the study
Exclusion
- Children receiving radiotherapy,
- taking ginger powder or vitamins to reduce nausea,
- children who did not want to participate in the study
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06120764
Start Date
November 10 2023
End Date
December 30 2025
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University İhsan Doğramacı Hospital
Ankara, Ankara, Turkey (Türkiye), 06100